Report: FDA’s Mifepristone Safety Review Could Be Completed by September

The news comes after the agency earlier this month confirmed that its review was moving into a new data analysis phase.

Tagged abortion drugsabortion pillschemical abortionFDAHHS Kyle Diamantasmifepristonemifepristone reviewmisoprostolTrump administrationU.S. Department of Health and Human ServicesU.S. Food and Drug Administration